These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21239721)

  • 1. TRIF is a critical survival factor in viral cardiomyopathy.
    Riad A; Westermann D; Zietsch C; Savvatis K; Becher PM; Bereswill S; Heimesaat MM; Lettau O; Lassner D; Dörner A; Poller W; Busch M; Felix SB; Schultheiss HP; Tschöpe C
    J Immunol; 2011 Feb; 186(4):2561-70. PubMed ID: 21239721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy.
    Rahnefeld A; Klingel K; Schuermann A; Diny NL; Althof N; Lindner A; Bleienheuft P; Savvatis K; Respondek D; Opitz E; Ketscher L; Sauter M; Seifert U; Tschöpe C; Poller W; Knobeloch KP; Voigt A
    Circulation; 2014 Oct; 130(18):1589-600. PubMed ID: 25165091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on the survival of mice with chronic ongoing myocarditis caused by Coxsackievirus B3.
    Seko Y; Takahashi N; Yagita H; Okumura K; Azuma M; Yazaki Y
    J Pathol; 1999 May; 188(1):107-12. PubMed ID: 10398149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.
    Westermann D; Savvatis K; Lindner D; Zietsch C; Becher PM; Hammer E; Heimesaat MM; Bereswill S; Völker U; Escher F; Riad A; Plendl J; Klingel K; Poller W; Schultheiss HP; Tschöpe C
    Circulation; 2011 Nov; 124(19):2082-93. PubMed ID: 21986287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
    Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
    Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.
    Henke A; Jarasch N; Martin U; Wegert J; Wildner A; Zell R; Wutzler P
    Int J Med Microbiol; 2008 Jan; 298(1-2):127-34. PubMed ID: 17897883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
    Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
    Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production.
    Fuse K; Chan G; Liu Y; Gudgeon P; Husain M; Chen M; Yeh WC; Akira S; Liu PP
    Circulation; 2005 Oct; 112(15):2276-85. PubMed ID: 16216974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of tumour necrosis factor (TNF) ligand superfamily co-stimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by Coxsackievirus B3.
    Seko Y; Takahashi N; Oshima H; Shimozato O; Akiba H; Takeda K; Kobata T; Yagita H; Okumura K; Azuma M; Nagai R
    J Pathol; 2001 Dec; 195(5):593-603. PubMed ID: 11745696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
    Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
    J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
    Huber SA
    Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T lymphocyte responses in CVB3-induced murine myocarditis.
    Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
    Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of tumour necrosis factor (TNF) receptor/ligand superfamily co-stimulatory molecules CD40, CD30L, CD27L, and OX40L in murine hearts with chronic ongoing myocarditis caused by coxsackie virus B3.
    Seko Y; Takahashi N; Oshima H; Shimozato O; Akiba H; Kobata T; Yagita H; Okumura K; Azuma M; Yazaki Y
    J Pathol; 1999 Aug; 188(4):423-30. PubMed ID: 10440754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional transgenic expression of TIR-domain-containing adaptor-inducing interferon-β (TRIF) in the adult mouse heart is protective in acute viral myocarditis.
    Xu Z; Desai M; Philip J; Sivsubramanian N; Bowles NE; Vallejo JG
    Basic Res Cardiol; 2011 Nov; 106(6):1159-71. PubMed ID: 21956162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
    Huber SA; Feldman AM; Sartini D
    Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer.
    Jiang Z; Xu W; Li K; Yue Y; Xu L; Ye F; Xiong S
    J Gene Med; 2008 Aug; 10(8):918-29. PubMed ID: 18512734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease.
    Liu P; Aitken K; Kong YY; Opavsky MA; Martino T; Dawood F; Wen WH; Kozieradzki I; Bachmaier K; Straus D; Mak TW; Penninger JM
    Nat Med; 2000 Apr; 6(4):429-34. PubMed ID: 10742150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus b3.
    Seko Y; Takahashi N; Yagita H; Okumura K; Yazaki Y
    J Pathol; 1997 Sep; 183(1):105-8. PubMed ID: 9370955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of interleukin-17A protects against coxsackievirus B3-induced myocarditis by increasing COX-2/PGE2 production in the heart.
    Xie Y; Chen R; Zhang X; Yu Y; Yang Y; Zou Y; Ge J; Chen H; Garzino-Demo A
    FEMS Immunol Med Microbiol; 2012 Apr; 64(3):343-51. PubMed ID: 22141571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.